ET
MIRM icon

Entropy Technologies’s Mirum Pharmaceuticals MIRM Stock Holding History

Entropy Technologies’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,797
Closed -$319K – 817
2023
Q4 		$319K Buy
+10,797
New +$327K 0.06% 433

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Entropy Technologies's MIRM Position: Q1 2024 in Review

Entropy Technologies sold out of Mirum Pharmaceuticals (MIRM) in Q1 2024, closing a stake of 10,797 shares — an estimated $319K sold.

Entropy Technologies first reported a position in MIRM in Q4 2023 and held it in 1 quarter. The position peaked at $319K in Q4 2023. 172 funds tracked by Wall St. Rank hold MIRM as of Q1 2024.

  • Entropy Technologies reported no remaining Mirum Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Entropy Technologies sold 10,797 Mirum Pharmaceuticals shares in Q1 2024, an estimated $319K.
  • Entropy Technologies first reported a position in Mirum Pharmaceuticals in Q4 2023 and held it in 1 quarter.
  • Entropy Technologies's Mirum Pharmaceuticals position peaked at $319K in Q4 2023.
  • 172 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2024.

Based on Entropy Technologies's 13F filing for Q1 2024, filed 8 May 2024.